MN Services Vermogensbeheer’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $36.8M | Buy |
+74,100
| New | +$32.8M | 0.28% | 72 |
|
|
2024
Q1 | – | Sell |
-121,500
| Closed | -$49.4M | – | 538 |
|
|
2023
Q4 | $49.4M | Sell |
121,500
-4,400
| -3% | -$1.63M | 0.45% | 59 |
|
|
2023
Q3 | $43.8M | Buy |
125,900
+3,200
| +3% | +$1.12M | 0.42% | 65 |
|
|
2023
Q2 | $43.2M | Sell |
122,700
-3,500
| -3% | -$1.18M | 0.4% | 66 |
|
|
2023
Q1 | $39.8M | Buy |
126,200
+2,800
| +2% | +$840K | 0.41% | 62 |
|
|
2022
Q4 | $35.6M | Sell |
123,400
-18,400
| -13% | -$5.61M | 0.4% | 63 |
|
|
2022
Q3 | $41.1M | Sell |
141,800
-7,800
| -5% | -$2.24M | 0.43% | 57 |
|
|
2022
Q2 | $42.2M | Sell |
149,600
-37,100
| -20% | -$9.93M | 0.39% | 63 |
|
|
2022
Q1 | $48.7M | Sell |
186,700
-11,700
| -6% | -$2.78M | 0.32% | 80 |
|
|
2021
Q4 | $43.6M | Buy |
198,400
+4,800
| +2% | +$933K | 0.26% | 98 |
|
|
2021
Q3 | $35.1M | Buy |
193,600
+2,900
| +2% | +$566K | 0.22% | 128 |
|
|
2021
Q2 | $32.4M | Buy |
+190,700
| New | +$39.9M | 0.25% | 105 |
|
|
2020
Q4 | $54.2M | Buy |
229,200
+4,400
| +2% | +$1.01M | 0.38% | 77 |
|
|
2020
Q3 | $61.2M | Buy |
224,800
+3,900
| +2% | +$1.08M | 0.48% | 53 |
|
|
2020
Q2 | $64.1M | Buy |
220,900
+2,200
| +1% | +$596K | 0.55% | 49 |
|
|
2020
Q1 | $52M | Sell |
218,700
-13,800
| -6% | -$3.17M | 0.58% | 47 |
|
|
2019
Q4 | $50.9M | Buy |
232,500
+5,900
| +3% | +$1.19M | 0.43% | 64 |
|
|
2019
Q3 | $38.4M | Buy |
226,600
+95,537
| +73% | +$16.9M | 0.36% | 81 |
|
|
2019
Q2 | $24M | Buy |
131,063
+87,100
| +198% | +$15.2M | 0.28% | 86 |
|
|
2019
Q1 | $8.09M | Buy |
43,963
+600
| +1% | +$111K | 0.09% | 233 |
|
|
2018
Q4 | $6.29M | Buy |
43,363
+2,500
| +6% | +$433K | 0.1% | 227 |
|
|
2018
Q3 | $7.88M | Buy |
40,863
+1,100
| +3% | +$196K | 0.18% | 120 |
|
|
2018
Q2 | $6.76M | Hold |
39,763
| – | – | 0.17% | 139 |
|
|
2018
Q1 | $6.48M | Buy |
39,763
+500
| +1% | +$81.7K | 0.17% | 138 |
|
|
2017
Q4 | $4.9M | Sell |
39,263
-1,600
| -4% | -$237K | 0.15% | 153 |
|
|
2017
Q3 | $6.21M | Hold |
40,863
| – | – | 0.16% | 145 |
|
|
2017
Q2 | $5.27M | Buy |
40,863
+34,248
| +518% | +$4.12M | 0.14% | 167 |
|
|
2017
Q1 | $676K | Buy |
6,615
+279
| +4% | +$24.6K | 0.13% | 175 |
|
|
2016
Q4 | $443K | Hold |
6,336
| – | – | 0.09% | 250 |
|
|
2016
Q3 | $553K | Buy |
6,336
+111
| +2% | +$10.5K | 0.11% | 215 |
|
|
2016
Q2 | $482K | Buy |
6,225
+84
| +1% | +$7.26K | 0.11% | 213 |
|
|
2016
Q1 | $428K | Buy |
+6,141
| New | +$555K | 0.1% | 233 |
|
Other funds holding VRTX
MN Services Vermogensbeheer's VRTX Position: Q2 2026 in Review
MN Services Vermogensbeheer opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 74,100 shares worth $36.8M. The stake represents 0.28% of the portfolio and ranks #72 among its holdings. This is a return to the name: MN Services Vermogensbeheer previously reported a position in VRTX as recently as Q4 2023.
MN Services Vermogensbeheer first reported a position in VRTX in Q1 2016 and has held it in 32 quarters since. The position peaked at $64.1M in Q2 2020. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- MN Services Vermogensbeheer held 74,100 shares of Vertex Pharmaceuticals worth $36.8M as of Q2 2026.
- Vertex Pharmaceuticals was a new MN Services Vermogensbeheer position in Q2 2026.
- Vertex Pharmaceuticals made up 0.28% of MN Services Vermogensbeheer's portfolio in Q2 2026, its #72 holding.
- MN Services Vermogensbeheer first reported a position in Vertex Pharmaceuticals in Q1 2016 and has held it in 32 quarters since.
- MN Services Vermogensbeheer's Vertex Pharmaceuticals position peaked at $64.1M in Q2 2020.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on MN Services Vermogensbeheer's 13F filing for Q2 2026, filed 31 Jul 2026.